申请人:Etern Biopharma (Shanghai) Co., Ltd.
公开号:EP4023639A1
公开(公告)日:2022-07-06
The present invention provides an amide pyrazole compound used as an FGFR irreversible inhibitor, a preparation method therefor, and use thereof. Specifically, the present invention provides a compound of formula 1, or a pharmaceutically acceptable salt thereof, or a solvate thereof, an isotopic substituent, a prodrug, or a metabolite. The compound of formula I has FGFR inhibiting activity, and can prevent or treat disorders related to FGFR activity or an expression quantity, such as, preferably, cancer.
本发明提供了一种用作FGFR不可逆抑制剂的酰胺吡唑化合物、其制备方法及其用途。具体而言,本发明提供了一种式 1 的化合物,或其药学上可接受的盐,或其溶液,或其同位素取代基,或其原药,或其代谢物。式 I 的化合物具有 FGFR 抑制活性,可预防或治疗与 FGFR 活性或表达量有关的疾病,如优选癌症。